Slingshot Biosciences

Sourcing reliable controls for cell therapy manufacturing is a hurdle worth discussing. Shore up your confidence in IND and BLA filings, including comparability studies. Learn more at https://hubs.li/Q02dcpsQ0 #Biotechnology #DrugDevelopment #FlowCytometry #CellTherapy #AnalyticalDevelopment #NoControlsNoConfidence

Discover how Slingshot Biosciences is advancing assay validation tools for #flowcytometry in T cell therapy development! In our latest article titled "Navigating the opportunities and challenges in analytical development of flow cytometry for T cell therapy", Therese Choquette (former Vallerskog) and Minh Ngoc Duong address the challenges faced in flow cytometry assay validation, while highlighting innovative solutions such as Slingshot Biosciences’ #cellmimics Dive into the full article now: https://lnkd.in/gvXXMqjB #cellbiology #flowcontrols #celltherapy

Stop by booth #5 at the 6th Annual Cell Therapy Analytical Development Summit in Boston, December 3rd - 5th to meet our experts - Christelle Catone and Annalise Barnette. They’ll be ready to discuss how our #cellmimics can enhance your #flowcytometry workflows. Don’t miss our poster presentation, “Cell Mimics as Reliable Controls for Consistent, Reproducible Flow Cytometry Assays in Cell Therapy” presented by Sarah (Sivers) Kotanchiyev, MLS(ASCP)CM, at Poster Session No. 4 in the Exhibition Space, starting at 4pm. Let’s discuss how cell mimics can elevate your #analyticaldevelopment — schedule a meeting with us during the show. https://lnkd.in/gGknE4t4 #celltherapy #cellmimics #cellandgene

Exciting news at Slingshot Biosciences! We are delighted to welcome Tiffany Salas-Morris as Chief Commercial Officer. "I am honored to join Slingshot Biosciences at such an exciting time in the company's growth," said Tiffany Salas-Morris. "The innovative work being done here has the potential to revolutionize current methodologies, and I am eager to contribute to our mission of helping scientists develop advanced therapies and reliable tests that improve patient outcomes." Jeff Kim, Founder, CEO, and President, shared: "We are thrilled to welcome Tiffany Salas-Morris to the Slingshot Biosciences team." "Tiffany's deep industry knowledge and proven track record in driving commercial success make her the ideal leader to help us scale our business and bring our innovative #cellmimics technology to a broader market." See the full press release here: https://lnkd.in/erAycQ7J #leadership #celltherapy #flowcytometry

Happy Halloween, LinkedIn ghouls and goblins! Are you still feeding your cell line monsters? It’s time to put down the nutrients and pick up Slingshot’s Cell Mimic Controls to slash your hands-on time by up to 95%! Let’s face it, nobody wants to spend their Halloween battling rogue cell lines and inconsistent results. Instead, let our mad scientists do the heavy lifting while saving you time and money! Speak to our team today and discover our frightfully good end-of-year deals.  https://lnkd.in/gEAjMdRu #CellLine #TrickorTreat #HappyHalloween #SlingshotBiosciences #Halloween #CellMimics #flowcytometry #MadScientists

Did you miss our recent article on streamlining #celltherapy quality control with cell mimics? Check it out to see how Slingshot Biosciences is helping to standardize #flowcytometry and #celltherapy with innovative, scalable cell mimics. We’d love to hear your thoughts and experiences—join the conversation by leaving a comment below!

Scientist Spotlight: Meet Jeff Kim, Ph.D., the Co-Founder and CEO of Slingshot Biosciences and Med Health Outlooks’s CEO of the Year in 2023. Jeff is a prolific entrepreneur who founded multiple companies including Radiant Genomics and Pattern AG before dedicating his attention to Slingshot Biosciences. “Today, at our core, Slingshot Biosciences strives to innovate and continually push the boundaries of what cell mimics can do. Our vision expands beyond controls for healthcare applications and toward active cell mimics with pharmaceutical functions. We have data that shows, even in complex applications such as cell and gene therapy, we can recapitulate the function of cell-based therapies from first principles using our proprietary platform and core technology.” At Slingshot Biosciences, Jeff’s vision is to overcome supply chain and cost barriers that restrict access to advanced therapeutics and diagnostics using cell mimics as analytical and functional controls that help scientists accelerate development of innovative solutions for human health. More about Slingshot Biosciences at https://lnkd.in/gBefRaaB

Discover TruCytes™—the revolutionary off-the-shelf, biomarker reference controls for your assay development. As the demand for reproducible and scalable controls in flow cytometry grows, TruCytes™ provide a game-changing solution for next-generation therapeutics. Read our latest blog to learn how TruCytes™ allow scientists to push the boundaries of therapeutic development: https://lnkd.in/g-rjQT9j #TruCytes #CellTherapy #CellMimics #BiotechInnovation #biomarkers #flowcytometry

In case you missed our webinar titled "Feasibility of an Immune Monitoring Panel with Drop-in Channels for Spectral Flow Cytometry", by Dr. Holly A. Jensen. The on-demand version is now available! Watch the full video here: https://lnkd.in/gCH7rmpH #flowcytometry #webinar #cellmimics #immunology

Cell therapy promises life-changing treatments, but quality control challenges can stall progress. Slingshot Biosciences cell mimics could be the breakthrough needed to simplify production and expand access. Dive deeper in the article below: #flowcytometry #celltherapy #cellmimics #cellbiology